Table 3 Clinical Response to Treatment
From: Evaluation of Different Combined Regimens in the Treatment of Cholinergic Urticaria
Variable | Group A, n (%) | Group B, n (%) | Group C, n (%) | P |
|---|---|---|---|---|
Itching | Â | Â | Â | Â |
   Increased | 27 (29.3) | 16 (20.8) | 14 (17.1) | 0.13 |
   Decreased | 49 (53.3) | 28 (36.4) | 25 (30.5) | 0.006 |
   Absent | 16 (17.4) | 33 (42.8) | 43 (52.4) | 0.0001 |
Weal | Â | Â | Â | Â |
   Increased | 34 (36.9) | 17 (22.1) | 6 (7.3) | 0.0001 |
   Decreased | 28 (30.4) | 12 (15.6) | 10 (12.2) | 0.005 |
   Absent | 31 (33.7) | 48 (62.3) | 66 (80.5) | 0.0001 |
Both itching and weal absent | 28 (30.4) | 64 (83.1) | 70 (85.4) | 0.0001 |
Eosinophil | Â | Â | Â | Â |
   Increased | 0 (0) | 0 (0) | 8 (9.8) | 0.002 |
   Decreased | 61 (66.3) | 74 (96.1) | 70 (85.4) | 0.0001 |
   Same | 31 (33.7) | 3 (3.9) | 4 (4.8) | 0.0001 |